Embryology

Former GOP Rep. Campaigning With Gun Giveaway To Fend Off ‘Looting Hordes From Atlanta’ – TPM

Use your AR-15 to fend off looting hordes from Atlanta. So says a former congressman whos trying to get back to the D.C. swamp.

As part of former Rep. Paul Brouns (R-GA) bid to get back to Congress, hes holding an AR-15 giveaway, he announced in a campaign video released Friday.

In uncertain times like these, the right to defend yourself, your property and your family could not be more important, the former member of Congress explains in the ad.

Give Brouns campaign your email, and you could win a liberty machine to protect yourself from looting hordes from Atlanta or a tyrannical government from Washington, he says.

Brouns well-known among observers of the right-wing fever swamps.

Ive come to understand that all that stuff I was taught about evolution and embryology and big bang theory all that is lies from the pit of hell, he famously told the Liberty Baptist Church Sportsmans Banquet in 2012, before adding that he believed the earth was 9,000 years old.

Broun, who proudly claimed in a previous Senate campaign to have been the first member of Congress to call former President Barack Obama a socialist, has pulled the gun-giveaway stunt before.

During that campaign, he said Obama would like nothing more than to ban the AR-15 and that, as a result, he was giving one way just fork over your name, email address and zip code.

Sen. David Perdue (R-GA) beat Broun in that primary and ultimately won the Senate seat.

Brouns latest video ends with him shooting at something off-camera. God bless America, the Georgia Republican says.

See the original post here:
Former GOP Rep. Campaigning With Gun Giveaway To Fend Off 'Looting Hordes From Atlanta' - TPM

Embryology

Spring term courses at the UO canceled due to remote learning – Oregon Daily Emerald

In response to the coronavirus pandemic, the University of Oregon has turned to providing classes remotely to its students. But some classes cant be taught online, and a number of students have experienced course cancellations, including courses taught at the Oregon Institute of Marine Biology campus and art and design classes.

Students in courses that included field or lab work were canceled due to the hands-on nature of these classes.

Marine biology majors at UO are required to spend a minimum of three terms at the OIMB campus in Charleston, Oregon. There, they engage in intensive field and lab classes that include working with live animals and going dredging on OIMBs research vessel, said Maya Watts, the education program coordinator for OIMB.

OIMB canceled four of its spring term courses, Watts said: Marine Ecology, Invertebrate Zoology, Embryology and Larval Ecology and Habitats of the Oregon Coast.

These courses couldnt be offered remotely as we cannot replicate full-day classes with numerous field trips, lab and microscope work, Watts said. It would be doing an injustice to the experience our students are expecting and looking forward to at OIMB.

Because of the requirement to spend academic terms in residence at OIMB, graduating seniors will face the challenge of meeting requirements for the marine biology major, said Craig Young, the director of OIMB.

The Oregon Institute of Marine Biology is located in Charleston, Oregon. (Cplow/Wikipedia)

Without these kinds of courses, the training of marine biologists is severely compromised, Young said. We are working to find ways that we can remedy these potential deficiencies as soon as the pandemic is over.

A few small studio classes offered to students in the UO School of Art + Design have also been canceled due to distance learning.

The Intro Jewel and Metals course, which explores developing and constructing jewelry and objects rooted in material culture, was canceled, according to the course catalog.

Josh Morris, a freshman and a product design major, registered for the course in early-March and was notified a week before spring term began that the class had been canceled.

It was kind of upsetting at first just because I had to figure out what I was going to do or like what class I was going to register for, Morris said. And it is a required studio class for product design, so that kind of messed up some of my overall four-year plan.

Landscape architecture classes such as Urban Farm and the topic class Trees Across Oregon, which teaches students about the diversity and wonder of Oregons trees, were also canceled, according to the course catalog.

Julia Treacy, a freshman who registered for Urban Farm, had been excited to immerse herself in the class and learn about farming.

That was going to be the class where I got to farm and learn about plants, Treacy said. Honestly, I thought it would be moved digitally somehow, so I was disappointed that didnt happen.

Urban Farm is offered during spring, summer and fall terms to students from any discipline at UO. In the class, students learn about where their food comes from and how their food choices affect change, according to the website.

Treacy felt like the participatory aspect of her learning had been disrupted due to spring term going online.

Urban Farm canceling took away another hands-on learning class, Treacy said. And I am more hands-on than a remote learner.

See the original post:
Spring term courses at the UO canceled due to remote learning - Oregon Daily Emerald

Biochemistry

‘Real Life’ Author Brandon Taylor On Why He Left Science – NPR

Author Brandon Taylor. William J. Adams/Riverhead Books hide caption

Author Brandon Taylor.

Brandon Taylor's story has a happy ending. Today he's a successful writer whose debut novel 'Real Life' received glowing reviews earlier this year. But his success only underscores what science lost when Brandon walked away from a graduate biochemistry program in 2016. He tells host Maddie Sofia why he left, and what he misses.

Read his essay in BuzzFeed, 'Working In Science Was A Brutal Education. That's Why I Left.'

Find and support your local public radio station at donate.npr.org/short.

Email the show at shortwave@npr.org.

This episode was produced by Brent Baughman, edited by Viet Le and fact-checked by Emily Vaughn.

Read more from the original source:
'Real Life' Author Brandon Taylor On Why He Left Science - NPR

Biochemistry

COVID-19 Impact on Automatic Biochemistry Analyzers Market Identify Which Types of Companies Could Potentially Benefit or Loose out From the Impact…

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Automatic Biochemistry Analyzers Market which would mention How the Covid-19 is Affecting the Automatic Biochemistry Analyzers Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Automatic Biochemistry Analyzers Players to Combat Covid-19 Impact.

The Global Automatic Biochemistry Analyzers Market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Researchs latest publication, Titled [Automatic Biochemistry Analyzers Market Research Report 2020], offers an insightful take on the drivers and restraints present in the market. It assesses the historical data pertaining to the global Automatic Biochemistry Analyzers market and compares it to the current market trends to give the readers a detailed analysis of the trajectory of the market. A team subject-matter experts have provided the readers a qualitative and quantitative data about the market and the various elements associated with it.

Global Automatic Biochemistry Analyzers Market is valued at USD XX million in 2020 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2020 to 2026.

Top Key Players of the Global Automatic Biochemistry Analyzers Market:Roche, Danaher, Siemens Healthcare, Abbott, Hitachi, Mindray Medical, Thermo Scientific, KHB, Abaxis, Horiba Medical, ELITech, Gaomi Caihong, Sunostik, Senlo, Sysmex, Urit, Tecom Science, Randox Laboratories, Dirui, Adaltis, Rayto

>>Get Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures):https://www.qyresearch.com/sample-form/form/1639743/global-automatic-biochemistry-analyzers-market

The Essential Content Covered in the Global Automatic Biochemistry Analyzers Market Report:Top Key Company Profiles.Main Business and Rival InformationSWOT Analysis and PESTEL AnalysisProduction, Sales, Revenue, Price and Gross MarginMarket Size And Growth RateCompany Market Share

Global Automatic Biochemistry Analyzers Market Segmentation By Product:Floor-standing, Bench-top

Global Automatic Biochemistry Analyzers Market Segmentation By Application:Primary Hospital, Provincial Hospital, Prefectural Hospital

In terms of region, this research report covers almost all the major regions across the globe such as North America, Europe, South America, the Middle East, and Africa and the Asia Pacific. Europe and North America regions are anticipated to show an upward growth in the years to come. While Automatic Biochemistry Analyzers Market in Asia Pacific regions is likely to show remarkable growth during the forecasted period. Cutting edge technology and innovations are the most important traits of the North America region and thats the reason most of the time the US dominates the global markets.Automatic Biochemistry Analyzers Market in South, America region is also expected to grow in near future.

Key questions answered in the report*What will be the market size in terms of value and volume in the next five years?*Which segment is currently leading the market?*In which region will the market find its highest growth?*Which players will take the lead in the market?*What are the key drivers and restraints of the markets growth?

>>>Request Customization of Report :https://www.qyresearch.com/customize-request/form/1639743/global-automatic-biochemistry-analyzers-market

Table of Content

1 Automatic Biochemistry Analyzers Market Overview1.1 Product Overview and Scope of Automatic Biochemistry Analyzers1.2 Automatic Biochemistry Analyzers Segment by Type1.2.1 Global Automatic Biochemistry Analyzers Production Growth Rate Comparison by Type 2020 VS 20261.2.2 Floor-standing1.2.3 Bench-top1.3 Automatic Biochemistry Analyzers Segment by Application1.3.1 Automatic Biochemistry Analyzers Consumption Comparison by Application: 2020 VS 20261.3.2 Primary Hospital1.3.3 Provincial Hospital1.3.4 Prefectural Hospital1.4 Global Automatic Biochemistry Analyzers Market by Region1.4.1 Global Automatic Biochemistry Analyzers Market Size Estimates and Forecasts by Region: 2020 VS 20261.4.2 North America Estimates and Forecasts (2015-2026)1.4.3 Europe Estimates and Forecasts (2015-2026)1.4.4 China Estimates and Forecasts (2015-2026)1.4.5 Japan Estimates and Forecasts (2015-2026)1.5 Global Automatic Biochemistry Analyzers Growth Prospects1.5.1 Global Automatic Biochemistry Analyzers Revenue Estimates and Forecasts (2015-2026)1.5.2 Global Automatic Biochemistry Analyzers Production Capacity Estimates and Forecasts (2015-2026)1.5.3 Global Automatic Biochemistry Analyzers Production Estimates and Forecasts (2015-2026)1.6 Coronavirus Disease 2019 (Covid-19): Automatic Biochemistry Analyzers Industry Impact1.6.1 How the Covid-19 is Affecting the Automatic Biochemistry Analyzers Industry1.6.1.1 Automatic Biochemistry Analyzers Business Impact Assessment Covid-191.6.1.2 Supply Chain Challenges1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Automatic Biochemistry Analyzers Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-191.6.3.1 Government Measures to Combat Covid-19 Impact1.6.3.2 Proposal for Automatic Biochemistry Analyzers Players to Combat Covid-19 Impact

2 Market Competition by Manufacturers2.1 Global Automatic Biochemistry Analyzers Production Capacity Market Share by Manufacturers (2015-2020)2.2 Global Automatic Biochemistry Analyzers Revenue Share by Manufacturers (2015-2020)2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.4 Global Automatic Biochemistry Analyzers Average Price by Manufacturers (2015-2020)2.5 Manufacturers Automatic Biochemistry Analyzers Production Sites, Area Served, Product Types2.6 Automatic Biochemistry Analyzers Market Competitive Situation and Trends2.6.1 Automatic Biochemistry Analyzers Market Concentration Rate2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue2.6.3 Mergers & Acquisitions, Expansion

3 Production Capacity by Region3.1 Global Production Capacity of Automatic Biochemistry Analyzers Market Share by Regions (2015-2020)3.2 Global Automatic Biochemistry Analyzers Revenue Market Share by Regions (2015-2020)3.3 Global Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.4 North America Automatic Biochemistry Analyzers Production3.4.1 North America Automatic Biochemistry Analyzers Production Growth Rate (2015-2020)3.4.2 North America Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.5 Europe Automatic Biochemistry Analyzers Production3.5.1 Europe Automatic Biochemistry Analyzers Production Growth Rate (2015-2020)3.5.2 Europe Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.6 China Automatic Biochemistry Analyzers Production3.6.1 China Automatic Biochemistry Analyzers Production Growth Rate (2015-2020)3.6.2 China Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.7 Japan Automatic Biochemistry Analyzers Production3.7.1 Japan Automatic Biochemistry Analyzers Production Growth Rate (2015-2020)3.7.2 Japan Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Automatic Biochemistry Analyzers Consumption by Regions4.1 Global Automatic Biochemistry Analyzers Consumption by Regions4.1.1 Global Automatic Biochemistry Analyzers Consumption by Region4.1.2 Global Automatic Biochemistry Analyzers Consumption Market Share by Region4.2 North America4.2.1 North America Automatic Biochemistry Analyzers Consumption by Countries4.2.2 U.S.4.2.3 Canada4.3 Europe4.3.1 Europe Automatic Biochemistry Analyzers Consumption by Countries4.3.2 Germany4.3.3 France4.3.4 U.K.4.3.5 Italy4.3.6 Russia4.4 Asia Pacific4.4.1 Asia Pacific Automatic Biochemistry Analyzers Consumption by Region4.4.2 China4.4.3 Japan4.4.4 South Korea4.4.5 Taiwan4.4.6 Southeast Asia4.4.7 India4.4.8 Australia4.5 Latin America4.5.1 Latin America Automatic Biochemistry Analyzers Consumption by Countries4.5.2 Mexico4.5.3 Brazil

5 Production, Revenue, Price Trend by Type5.1 Global Automatic Biochemistry Analyzers Production Market Share by Type (2015-2020)5.2 Global Automatic Biochemistry Analyzers Revenue Market Share by Type (2015-2020)5.3 Global Automatic Biochemistry Analyzers Price by Type (2015-2020)5.4 Global Automatic Biochemistry Analyzers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Global Automatic Biochemistry Analyzers Market Analysis by Application6.1 Global Automatic Biochemistry Analyzers Consumption Market Share by Application (2015-2020)6.2 Global Automatic Biochemistry Analyzers Consumption Growth Rate by Application (2015-2020)

7 Company Profiles and Key Figures in Automatic Biochemistry Analyzers Business7.1 Roche7.1.1 Roche Automatic Biochemistry Analyzers Production Sites and Area Served7.1.2 Roche Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.1.3 Roche Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.1.4 Roche Main Business and Markets Served7.2 Danaher7.2.1 Danaher Automatic Biochemistry Analyzers Production Sites and Area Served7.2.2 Danaher Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.2.3 Danaher Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.2.4 Danaher Main Business and Markets Served7.3 Siemens Healthcare7.3.1 Siemens Healthcare Automatic Biochemistry Analyzers Production Sites and Area Served7.3.2 Siemens Healthcare Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.3.3 Siemens Healthcare Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.3.4 Siemens Healthcare Main Business and Markets Served7.4 Abbott7.4.1 Abbott Automatic Biochemistry Analyzers Production Sites and Area Served7.4.2 Abbott Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.4.3 Abbott Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.4.4 Abbott Main Business and Markets Served7.5 Hitachi7.5.1 Hitachi Automatic Biochemistry Analyzers Production Sites and Area Served7.5.2 Hitachi Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.5.3 Hitachi Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.5.4 Hitachi Main Business and Markets Served7.6 Mindray Medical7.6.1 Mindray Medical Automatic Biochemistry Analyzers Production Sites and Area Served7.6.2 Mindray Medical Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.6.3 Mindray Medical Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.6.4 Mindray Medical Main Business and Markets Served7.7 Thermo Scientific7.7.1 Thermo Scientific Automatic Biochemistry Analyzers Production Sites and Area Served7.7.2 Thermo Scientific Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.7.3 Thermo Scientific Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.7.4 Thermo Scientific Main Business and Markets Served7.8 KHB7.8.1 KHB Automatic Biochemistry Analyzers Production Sites and Area Served7.8.2 KHB Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.8.3 KHB Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.8.4 KHB Main Business and Markets Served7.9 Abaxis7.9.1 Abaxis Automatic Biochemistry Analyzers Production Sites and Area Served7.9.2 Abaxis Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.9.3 Abaxis Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.9.4 Abaxis Main Business and Markets Served7.10 Horiba Medical7.10.1 Horiba Medical Automatic Biochemistry Analyzers Production Sites and Area Served7.10.2 Horiba Medical Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.10.3 Horiba Medical Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.10.4 Horiba Medical Main Business and Markets Served7.11 ELITech7.11.1 ELITech Automatic Biochemistry Analyzers Production Sites and Area Served7.11.2 ELITech Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.11.3 ELITech Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.11.4 ELITech Main Business and Markets Served7.12 Gaomi Caihong7.12.1 Gaomi Caihong Automatic Biochemistry Analyzers Production Sites and Area Served7.12.2 Gaomi Caihong Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.12.3 Gaomi Caihong Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.12.4 Gaomi Caihong Main Business and Markets Served7.13 Sunostik7.13.1 Sunostik Automatic Biochemistry Analyzers Production Sites and Area Served7.13.2 Sunostik Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.13.3 Sunostik Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.13.4 Sunostik Main Business and Markets Served7.14 Senlo7.14.1 Senlo Automatic Biochemistry Analyzers Production Sites and Area Served7.14.2 Senlo Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.14.3 Senlo Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.14.4 Senlo Main Business and Markets Served7.15 Sysmex7.15.1 Sysmex Automatic Biochemistry Analyzers Production Sites and Area Served7.15.2 Sysmex Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.15.3 Sysmex Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.15.4 Sysmex Main Business and Markets Served7.16 Urit7.16.1 Urit Automatic Biochemistry Analyzers Production Sites and Area Served7.16.2 Urit Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.16.3 Urit Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.16.4 Urit Main Business and Markets Served7.17 Tecom Science7.17.1 Tecom Science Automatic Biochemistry Analyzers Production Sites and Area Served7.17.2 Tecom Science Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.17.3 Tecom Science Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.17.4 Tecom Science Main Business and Markets Served7.18 Randox Laboratories7.18.1 Randox Laboratories Automatic Biochemistry Analyzers Production Sites and Area Served7.18.2 Randox Laboratories Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.18.3 Randox Laboratories Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.18.4 Randox Laboratories Main Business and Markets Served7.19 Dirui7.19.1 Dirui Automatic Biochemistry Analyzers Production Sites and Area Served7.19.2 Dirui Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.19.3 Dirui Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.19.4 Dirui Main Business and Markets Served7.20 Adaltis7.20.1 Adaltis Automatic Biochemistry Analyzers Production Sites and Area Served7.20.2 Adaltis Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.20.3 Adaltis Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.20.4 Adaltis Main Business and Markets Served7.21 Rayto7.21.1 Rayto Automatic Biochemistry Analyzers Production Sites and Area Served7.21.2 Rayto Automatic Biochemistry Analyzers Product Introduction, Application and Specification7.21.3 Rayto Automatic Biochemistry Analyzers Production Capacity, Revenue, Price and Gross Margin (2015-2020)7.21.4 Rayto Main Business and Markets Served

8 Automatic Biochemistry Analyzers Manufacturing Cost Analysis8.1 Automatic Biochemistry Analyzers Key Raw Materials Analysis8.1.1 Key Raw Materials8.1.2 Key Raw Materials Price Trend8.1.3 Key Suppliers of Raw Materials8.2 Proportion of Manufacturing Cost Structure8.3 Manufacturing Process Analysis of Automatic Biochemistry Analyzers8.4 Automatic Biochemistry Analyzers Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers9.1 Marketing Channel9.2 Automatic Biochemistry Analyzers Distributors List9.3 Automatic Biochemistry Analyzers Customers

10 Market Dynamics10.1 Market Trends10.2 Opportunities and Drivers10.3 Challenges10.4 Porters Five Forces Analysis

11 Production and Supply Forecast11.1 Global Forecasted Production of Automatic Biochemistry Analyzers (2021-2026)11.2 Global Forecasted Revenue of Automatic Biochemistry Analyzers (2021-2026)11.3 Global Forecasted Price of Automatic Biochemistry Analyzers (2021-2026)11.4 Global Automatic Biochemistry Analyzers Production Forecast by Regions (2021-2026)11.4.1 North America Automatic Biochemistry Analyzers Production, Revenue Forecast (2021-2026)11.4.2 Europe Automatic Biochemistry Analyzers Production, Revenue Forecast (2021-2026)11.4.3 China Automatic Biochemistry Analyzers Production, Revenue Forecast (2021-2026)11.4.4 Japan Automatic Biochemistry Analyzers Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast12.1 Global Forecasted and Consumption Demand Analysis of Automatic Biochemistry Analyzers12.2 North America Forecasted Consumption of Automatic Biochemistry Analyzers by Country12.3 Europe Market Forecasted Consumption of Automatic Biochemistry Analyzers by Country12.4 Asia Pacific Market Forecasted Consumption of Automatic Biochemistry Analyzers by Regions12.5 Latin America Forecasted Consumption of Automatic Biochemistry Analyzers13 Forecast by Type and by Application (2021-2026)13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)13.1.1 Global Forecasted Production of Automatic Biochemistry Analyzers by Type (2021-2026)13.1.2 Global Forecasted Revenue of Automatic Biochemistry Analyzers by Type (2021-2026)13.1.2 Global Forecasted Price of Automatic Biochemistry Analyzers by Type (2021-2026)13.2 Global Forecasted Consumption of Automatic Biochemistry Analyzers by Application (2021-2026)14 Research Finding and Conclusion

15 Methodology and Data Source15.1 Methodology/Research Approach15.1.1 Research Programs/Design15.1.2 Market Size Estimation15.1.3 Market Breakdown and Data Triangulation15.2 Data Source15.2.1 Secondary Sources15.2.2 Primary Sources15.3 Author List15.4 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Read the original here:
COVID-19 Impact on Automatic Biochemistry Analyzers Market Identify Which Types of Companies Could Potentially Benefit or Loose out From the Impact...

Biochemistry

Five named SUNY Distinguished Professors – UB Now: News and views for UB faculty and staff – University at Buffalo Reporter

Campus News

UBNOW STAFF

Five UB faculty members have been named SUNY Distinguished Professors,the highest faculty rank in the SUNY system.

M. Laura Feltri, Jo Freudenheim, Amit Goyal, Elad Levy and Stephen Tiffany were appointed to the distinguished professor ranks by the SUNY Board of Trustees at its meeting on March 17.

The rank of distinguished professor is an order above full professorship and has three co-equal designations: distinguished professor, distinguished service professor and distinguished teaching professor.

The five were all named distinguished professors in recognition of their international prominence and distinguished reputations within their chosen fields. According to SUNY, this distinction is attained through significant contributions to the research literature or through artistic performance or achievement in the case of the arts. The candidates work must be of such character that the individuals presence will tend to elevate the standards of scholarship of colleagues both within and beyond these persons academic fields.

UB is tremendously proud that five of our most distinguished faculty members have been appointed to SUNYs highest rank, said A. Scott Weber, provost and executive vice president for academic affairs. This distinction recognizes that UB faculty are among the best in the world and have a transformative impact through their sustained research and scholarship contributions.

UBs newest SUNY Distinguished Professors:

M. Laura Feltri, SUNY Distinguished Professor of Biochemistry

Feltri, professor of biochemistry and neurology in the Jacobs School of Medicine and Biomedical Sciences and acting director of the Hunter James Kelly Research Institute, is an internationally renowned expert and pioneer in the study of myelin diseases in the nervous system. She conducts research on Schwann cells and disorders that affect the peripheral or central nervous systems, like Charcot-Marie-Tooth disease, multiple sclerosis or Krabbe leukodystrophy.

With the undergraduate, graduate and postdoctoral students she has mentored, Feltri has made numerous seminal discoveries in her field, including developing the first mutagenesis tool for studying Schwann cell development and the signals that regulate myelination. In collaboration with Lawrence Wrabetz, she pioneered the use of transgenic animal to model neurological diseases and develop new therapies.

An internationally recognized leader in the biology of nervous system myelination, her fundamental research is contributing to the development of novel therapies for neurological disorders.

Feltri serves as chair of the Cellular and Molecular Biology of Glia National Institutes of Health study session, as a board member of scientific organizations and on the editorial board of various journals.

Jo Freudenheim, SUNY Distinguished Professor of Epidemiology and Environmental Health

Freudenheim, UB Distinguished Professor and chair of the Department of Epidemiology and Environmental Health in the School of Public Health and Health Professions, is an internationally renowned expert in cancer epidemiology. She has conducted seminal research to understand factors that influence risk for cancer, particularly breast cancer, including the role of diet, alcohol and the physical environment. She uses a variety of methodologically rigorous approaches (e.g., molecular epidemiology) to examine carcinogenesis, from the molecular level to the individual and population levels.

Her research has been funded for more than 25 years by the NIH and other federal funding agencies. She has authored more than 275 peer-reviewed publications in national and international high-impact journals, where they have helped shape the field of chronic disease epidemiology.

A frequent reviewer for such entities as the National Cancer Institute, the American Cancer Society and the Canadian Foundation for Innovation, she also has contributed to the field by serving as a mentor to graduate students and postdoctoral fellows, and in her role as director of a cancer epidemiology training program.

Amit Goyal, SUNY Distinguished Professor of Materials Science

An internationally recognized materials scientist, Goyal is a SUNY Empire Innovation Professor and founding director of UBs RENEW Institute. In 2018, he was elected to the National Academy of Engineering for groundbreaking scientific advances and technological innovations enabling the worldwide commercialization of high-temperature superconductors. He is also a fellow of the National Academy of Inventors, with 87 issued patents and additional patents pending.

Goyal joined UB in 2015 to direct RENEW, an institute that harnesses the expertise of more than 100 faculty in seven UB schools and colleges to explore solutions to globally pressing energy and environmental problems, as well as the social and economic issues connecting them. His leadership has placed UB at the forefront of efforts to reduce water and air pollution, and find innovative, clean ways to produce, transmit and store energy.

In 2019, he was awarded the UB Presidents Medal that recognizes outstanding scholarly or artistic achievements, humanitarian acts, contributions of time or treasure, exemplary leadership or any other major contribution to the development of the University at Buffalo and the quality of life in the UB community.

The author or co-author of more than 350 technical publications and co-editor of six books, Goyal was ranked by Thompson-Reuters Essential Science Indicators as the most cited author worldwide in the field of high-temperature superconductivity from 1999-2009. He is a fellow of eight professional societies: the American Association for Advancement of Science, the Materials Research Society, the American Physical Society, the World Innovation Foundation, the American Society of Metals, the Institute of Physics, the American Ceramic Society and the World Technology Network. He serves on several scientific advisory boards and on several National Academy review panels.

Elad I. Levy, SUNY Distinguished Professor of Neurosurgery

Levy, professor and chair of the Department of Neurosurgery in the Jacobs School, is an internationally renowned expert in stroke and cerebrovascular neurosurgery, and a major contributor to the service of organized neurosurgery. Widely regarded as one of the pioneers in this field, Levy has published extensively and developed new technology and approaches that have been instrumental in helping treat people around the world with previously incurable cerebrovascular disorders.

A member and fellow of the American Association of Neurological Surgeons, the American College of Surgeons and the American Heart Association/American Stroke Association, Levy has achieved additional national and international prominence as one of 100 members of the American Academy of Neurosurgery and one of 12 members of the American Board of Neurosurgery.

He serves as secretary of the Congress of Neurological Surgeons and director of the American Board of Neurological Surgery.

Stephen Tiffany, SUNY Distinguished Professor of Psychology

The Empire Innovation Professor in the Department of Psychology, Tiffany is world-renowned expert on the study of addictions, developing theoretical models that have shaped the way experts in the field conceptualize the relationship between craving and addictive behavior.

Actively involved in numerous clinical studies many of which focus on nicotine Tiffany conducts empirical research with people and animal models using a combination of controlled experimentation and more translational work. He provided a dominant theoretical perspective on craving and its relationship to drug use with his 1990 Psychological Review paper that outlined a cognitive model of craving now referred to as the Tiffany model.

An extraordinarily productive and prolific researcher, Tiffany has more than 100 publications in highly prestigious journals and has received multiple grants from the National Science Foundation and the NIH.

He has served as a standing member of three different NIH review panels and on the editorial boards of multiple journals.

A UB faculty member since 2007, Tiffany served as chair of the Department of Psychology from 2011-18.

See the article here:
Five named SUNY Distinguished Professors - UB Now: News and views for UB faculty and staff - University at Buffalo Reporter

Biochemistry

They create a toilet that recognizes the user; seeks to detect diseases – InTallaght

The smart toilet can analyze urinary and intestinal tract diseases; the data is completely private

The University of Stanford he has createsdo a toilet with Artificial Intelligence (AI) capable of scan he rear or straight -Analprint Scan- of the user. Its objective? Be able to detectsr diseases in faeces and urine through an advanced system of cameras and sensors.

An investigation published in the magazine Nature Biomedical Engineering, describes a toilet that, in addition to detecting the user using it through a anal print or Analprint ScanIt is also capable of detecting and preventing diseases -diabetes, urinary infections, inflammation of the intestine, among others.

According to the Stanford researchers, the prototype bathroom has been tested on more than 20 people and Artificial Intelligence has been able to detect each user through image recognition, something similar with fingerprint detection -which also has on the toilet lever- and recognition facial.

Smart Toilet PrototypeNature Biomedical Engineering

This anus scan relates the data obtained with each user without making a mistake and, according to the developers of this new toilet, it is a device that has increased in value not only because it is capable of detecting diseases but also because it is an object in common use. since data that is normally ignored is used.

Recordings of feces and urine collected by the toilet are processed by algorithms to detect possible patterns like urodynamic -urine volume and flow time-and even the viscosity in the feces which is activated when sitting down.

In addition to measuring the pressure and movement of waste Bristol scale These are classified according to a clinical scale of morphological function, in addition to their sample-type biochemical analysis and response, such as genomics and microbiotics.

To top it off with the four detection chambers, the device has urine test strips that analyze the basic biochemistry of the urine, such as pH, glucose, proteins or enzymes that help detect possible infections.

Biometric identificationNature Biomedical Engineering

These data that are collected are uploaded to a cloud system -always maintaining privacy- so that doctors can access them because, although it is a serious investigation, 30% of users they felt uncomfortable when using it and they were concerned about the privacy of their data.

Read the original here:
They create a toilet that recognizes the user; seeks to detect diseases - InTallaght

Biochemistry

Lice Drug Ivermectin Shown to Kill COVID-19 Within 48 Hours – Newsmax

Researchers in Australia say head lice drug Ivermectin quickly prevented replication of SARS-CoV-2, the virus that causes COVID-19.

The drug, which has been used to treat and prevent diseases related to parasites in humans, pets, and livestock since the 1980s, was used in a laboratory setting with positive results.

Researchers infected cells with the virus, then exposed them to Ivermectin.

"We showed that a single dose of Ivermectin could kill COVID-19 in a petri dish within 48 hours, indicating potent antiviral activity," says study co-author David Jans, PhD, a professor of biochemistry and molecular biology at Monash University in Melbourne.

Even at 24 hours, "there was a really significant reduction" in the virus, study leader Kylie Wagstaff, PhD, a senior research fellow in biochemistry and molecular biology at Monash University, said in a statement,according to WebMd.

Still, experts say more testing is needed.

"The results are promising," says Katherine Seley-Radtke, PhD, a professor of chemistry and biochemistry at the University of Maryland, Baltimore County.

Jans says the drug is "safe at relatively high doses."

"It is important to stress that no one should try to self-medicate with versions of Ivermectin that are for veterinary purposes or head lice," he says.

2020 Newsmax. All rights reserved.

Read the original post:
Lice Drug Ivermectin Shown to Kill COVID-19 Within 48 Hours - Newsmax

Physiology

The patient gains substantially with combination of imaging and physiology : Dr. Shirish Hiremath (MS) – ETHealthworld.com

Shahid Akhter, Editor, ETHealthworld spoke to Dr. Shirish Hiremath (MS), Consultant Cardiologist and Director, Cardiac Cath Lab, Ruby Hall Clinic, Pune to know more about patients' clinical outcome amidst life saving medical devices. Edited excerpts:

Multi-vessel Coronary Artery Disease : Trends in IndiaClearly in India especially the multi vessel disease is growing rapidly. This is primarily because the Indians get the disease at a younger age. So, if somebody picks it up at the age of 35 or 40, by the time he gets to 80 it's always going to be multi vessel disease. Clearly, its something which is very important for this country.

All are important. Generally, I would imagine that when you sit in a car you put your seatbelt that's like taking care and taking aggressive medical therapy and continuing. But when an event happens the air bags come out so the angioplasty or a bypass surgery is like an emergency measure where artery or a person who is on a downward trend comes out very effectively and is ready to live effective life subsequently.

We are also spreading our wings to multi vessel disease, complex coronary angioplasties. So, for this you need a good support. So initially like say we use to have aortic balloon pump for somebody who had low blood pressure. Today, we have few devices like Ampyra, which make life very easy for angioplaster to give effective results.

More importantly, a conventional angioplasty can be perfected by doing testing at the end of the procedure. This can be done at the beginning of the procedure and repeated at the end of the procedures so we are talking of IVUS or OCT and this is to decide what kind of therapy we should be using. We have multiple options not anymore just balloon and stent.

It could be cutting balloon or scoring balloon or shockwave balloon or high pressure non-compliant balloon and so on. Also, there are procedures which soften a harden vessel which is so very crucial for a good stent placement. All these techniques can be implemented in each case according to the need and this is brought out by imaging before.

Imaging at the end of the procedure tells you that whether your stent is very effectively placed in a vessel, the result is acceptable, it will go for years and years very effectively.

So, either way, the patient gains substantially with combination of imaging and physiology. Absolutely, if you will see the evolution of angioplasty world over and especially in India, where we started doing angioplasty in 1987. Its almost three decades of angioplasty in India and we clearly realise that we were doing early in early years and the way we are doing today the newer technology has clearly benefitted. We are so confident. In fact, this debate comes up when we talk of the comparison for multi vessel disease between bypass surgery on one side and angioplasty on the other side. Innovation in medical devices : improved successWe have this SYNTAX study earlier which clearly indicated that if you have a high SYNTAX score or moderate SYNTAX score surgery is better. Same SYNTAX few years later was done as SYNTAX tool in which lot of physiology was used and lot of imaging was used and that clearly shows that angioplasty results can be very close to the surgical results. So, this is the kind of gain we have gained while perfecting the angioplasty with imaging and physiology.

Choice of stent : Who decides ?When I am talking to the patient and its family. What kind of stents? We tell them that this this this is available to you and I clearly tell them no one stent is the best in the world for everybody. It depends a lot on what kind of linear stent that you need from the stent, what kind of tortuosity through which the stent must go. Its the bed which is simple or difficult. The stent performance can change so we always take a lot of effort to create a good bed for the stent to land.

So, today stents performed well. The deliverability is of course very important, and this is where stents have improved the great deal so not only the stent thickness but the shaft, the way the stent is crimped on the balloon, everything has changed. So, the stents are getting easier and easier to deliver. Also, we have techniques like Guide Catheter Extension which can help you to take the stent to a correct location relatively easily and that's how the stent delivery is not any more an issue.

However, the stent will have its own sort of specifications, which make them run for longer years and this is where I would feel I tell the patients that this particular stent has this much documentation, this much data and this is going to be my choice for your case and it depends on person to person and patient to patient.

Excerpt from:
The patient gains substantially with combination of imaging and physiology : Dr. Shirish Hiremath (MS) - ETHealthworld.com

Physiology

Together all the time: An expert’s advice for maintaining a positive relationship while at home – Las Vegas Weekly

Youve memorized the curves of that face. Youd recognize that laugh anywhere. And to you, that voice makes the sweetest sound in the world.

But now its going on Week Four of the COVID-19 lockdown. Youre working from home. Your partner is working from home. The toilet paper is running low. And youre not feeling so warm and fuzzy about that face, that laugh or that voice.

Were at a place where everyone is anxious, and theyre all sharing the same space, says Dr. Katherine Hertlein, a professor in UNLVs Couple and Family Therapy program. The coping strategies that we used to use before, we dont have anymore. You cant go out shopping. You cant go to the gym. So now were stuck in the house. Weve got a very high level of anxiety, because this is really a very serious issue. So this creates challenges for some couples, because they werent aware that they were using some of those individual strategies to cope before.

Was your partner using the last of the milk really what caused you to explode? Or was it those four hours glued to CNN or reading yet another news story about COVID-19 that began to affect your attitude toward one another?

Youre upset and angry or let down by the government, your senator, your employer,and it seems out of your controlthats really just your grief, Hertlein says. You have to acknowledge the grief. Life has changed. Your world has changed. Sit in that grief.

Hertleins second tip: Recognize that everything has changed. If you go through your world and pretend like it hasnt, that tends to come out as physical symptomologyyoure getting headaches more often, your stomach is tight, your shoulders are tight. Your body is your first indicator that something is going on, and were really good at ignoring our body. So check in with your body and make sure youre feeling what you need to feel to get through each moment.

And third: You have to have some type of strategy to negotiate with your partner about the rules that have now changed.

For some couples, more time together can be no big deal. For others its a huge departure. Before playing a heated round of the blame game, sit down with your partner to make a plan. Discuss and decide: Whos in charge of the kids? Whos going to cook dinner tonight? Who gets to choose the next show to stream?

When we think about couples and change and process, we need to be thinking about the assumption of good intent, Hertlein says. What are some things where you can still look at your partner and say, They still have good intentions toward me, and I have good intentions toward my partner. You have to have this active strategy about looking for those opportunities of good intent.

Remember that your partner holds you in high regard and you hold them in high regard, and there are good intentions even if theres a misstep along the way in terms of the roles and rules and how youre going to negotiate things.

Remember, youre in this together. Take the time to laugh. Fall in love all over again with that face and look to your partner as your rock in an ocean of uncertainty.

How to defuse aheated argument

Hertlein says research shows its best to take a physical time-out. Separate from one another for at least 20 minutes to calm your physiology. Then come back to the conversation, so the partner knows you havent forgotten about them.

Where to get help

Hertlein recommends these local teletherapycounseling options:

Bridge Counseling 702-474-6450

ICLV Wellness Center 702-673-4745

Kayenta Therapy 702-438-7800

Next Chapter Therapy 702-508-5920

Pathways Therapy and Wellness Center 702-363-7284

See original here:
Together all the time: An expert's advice for maintaining a positive relationship while at home - Las Vegas Weekly

Neuroscience

WVU Rockefeller Neuroscience Institute and Oura Health unveil study to predict the outbreak of COVID-19 in healthcare professionals – WVU Medicine

Posted on 4/8/2020

(Editors note: A media tool kit with photos, videos and additional resources is available in the WVUToday Media Center.)

MORGANTOWN, W.VA. -- The West Virginia University Rockefeller Neuroscience Institute, WVU Medicine, and smart ring maker Oura Health today (April 8) announced a national study designed to accelerate early detection of the COVID-19 virus symptoms and contagiousness. Leveraging an artificial intelligence -driven predictive model, wearable ring technology, and a COVID-19 monitoring app, RNI scientists and partners are developing an innovative digital PPE approach that potentially can identify infected frontline healthcare professionals before they become symptomatic a possible breakthrough in monitoring capabilities and limiting the spread.

The RNIs approach not only measures the onset of increased body temperature from the Oura ring and physical symptoms but goes beyond that by looking at the individual holistically integrating physiologic measures with psychological, cognitive and behavioral biometrics, such as stress and anxiety. In real-time, this holistic approach can provide an early and more comprehensive assessment, tracking the mind-body connection and homeostasis in the context of asymptomatic infection. Through this analysis, the team can forecast and predict the onset of fever, cough, fatigue and other physical symptoms linked to viral infections.

Over the past three weeks, Oura smart rings and the RNI COVID-19 monitoring smartphone app have been deployed to physicians, nurses and other frontline healthcare workers in the ED, ICU, testing sites, and urgent care settings in West Virginia. In addition, the RNI is partnering with hospitals across the country, including those in New York City, Philadelphia, Nashville and other critical emerging areas, to monitor more than 1,000 front-line healthcare personnel with exposure to COVID-19.

We are continuously monitoring the mind-body connectivity through our integrated neuroscience platform measuring the autonomic nervous system, fatigue, anxiety, circadian rhythms, and other human resilience and recovery functions, Dr. Ali Rezai, executive chair of the WVU Rockefeller Neuroscience Institute, said. Our AI-driven models are currently predicting symptoms 24 hours prior to onset, and we are working toward a three-plus day forecast. This forecasting capability will help us get ahead of this pandemic; limit the spread to protect healthcare workers, their families, and our communities; and improve our understanding of health recovery.

More broadly, the RNI is continuously monitoring and analyzing more than 30,000 subjects through its integrative neuroscience approach, gaining insight and predictive success in chronic pain, addiction, aging and other illnesses, as well as the readiness and recovery of our military.

At Oura, weve heard firsthand from our users how the physiological signals tracked by the ring have predicted the onset of the virus before other symptoms manifest, Harpreet Rai, CEO of Oura Health, said. Were grateful we can apply this knowledge to help vulnerable caregivers swiftly identify the earliest signs of the disease, and take the appropriate protective measures to limit its spread.

We have done extensive research in the wearable space, and Ouras accuracy and usability is unparalleled to anything we have tested, Rezai added, We are proud to partner with Oura and its innovation to serve our population.

About the Rockefeller Neuroscience InstituteWe are improving lives by pioneering advances in brain health. With the latest technologies, an ecosystem of partners, and a truly integrated approach, we are making tangible progress. Our goal is to combat public health challenges ranging from addiction to Alzheimers, benefiting people in West Virginia, neighboring states, and beyond. Learn more about the RNIs first-in-the-world clinical trials and the top caliber experts joining us in our mission. For more information, visit http://www.wvumedicine.org/rni/.

About Oura HealthOura Health helps people improve their sleep, better understand their bodies, and reach their goals. The Oura Ring and app track all stages of sleep and activity to provide daily feedback and practical steps to inspire healthy lifestyles. Founded in 2013, Oura Health has raised $47M of funding from Forerunner Ventures, Gradient, Square Inc. and MSD Capital, and angel investors. Oura Health is headquartered in Oulu, Finland, with offices in Helsinki and San Francisco. For more information, visit http://ouraring.com/.

More:
WVU Rockefeller Neuroscience Institute and Oura Health unveil study to predict the outbreak of COVID-19 in healthcare professionals - WVU Medicine